News
-
-
-
-
-
PRESS RELEASE
Press Release: Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease
Sanofi's MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease. Expanded indication for broad protection. Key milestone in public health -
-
-
-
-